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We support in-
creased reimburse-
ment for primary
care, but to reward
primary care by
eliminating private
practice of cardiol-
ogy is the wrong
methodology . . .n the days of bow-and-arrow warfare, the most effective target for an arrow was the
heart. The federal government recently revived that concept by targeting cardiovascular
care for payment cuts that ultimately will become fatal to the practice of cardiology. In
2 years of practice, I have not witnessed such disdain as our own government expresses for
ardiologists, nor have I witnessed such animosity among medical specialties.
The disdain seems to come from concerns about cost. The government blames cardiolo-
ists for overuse and driving excess cost in health care. However, cardiovascular disease con-
titutes more than 40% of Medicare costs. What our legislators forget is that cardiovascular
isease is the greatest cause of hospital admissions in the country, the highest cause for mor-
ality, and the disorder that has seen the most improvement in survival over the past 30 years
with nearly 30% mortality reduction since 1995) (1). The reduction in mortality is not by
hance. We have significantly improved outcome through a combination of robust treatment
nd prevention programs to lower cardiovascular risk, and through interventions like coro-
ary artery bypass grafts, percutaneous coronary interventions, implantable cardioverter-
efibrillators, pacemakers, new heart valves, and so on. We created thrombolytic therapy for
cute myocardial infarction, the door-to-balloon emergency percutaneous coronary interven-
ion concept that has saved innumerable lives (2), implantable cardioverter-defibrillator and
ardiac resynchronization therapy for end-stage heart failure, and many other new therapies
hat have kept patients alive with a high quality of life for many years beyond prior life ex-
ectancies. We have been pioneers in developing evidence-based guidelines and performance
easures to provide the best quality care for our patients. None of this therapy comes with-
ut a cost, and in terms of the benefit measured in quality-adjusted life-years, all of these
herapies have been accepted by medicine and society as being cost-effective. Eliminating this
evel of cardiology care may reduce the cost of health care in the short term, but at the risk
f greater mortality and less innovation. The end result may, in fact, be an increase in cost as
any of the office-based imaging procedures are moved into a hospital setting with often
ore than double the cost.
The most egregious effort at damaging cardiology comes from recent decisions by the
enters for Medicare and Medicaid Services (CMS) to accept without question spurious
ata from the American Medical Association Physician Practice Information Survey (3).
ased on this data, the CMS 2010 Physician Fee Schedule would reduce cardiology reim-
ursement to levels that would destroy most private practices. Medicare leads this effort, but
rivate insurers will follow when they see an opportunity to increase profits. Indeed, this is
lready happening in some areas of the country where insurers are harassing cardiologists to
he point that it is impossible to obtain “permission” to perform needed studies for good
are. The insult is compounded by the requirement for a physician to converse about the
omplexities of care with insurance representatives whose lack of expertise can delay ef-
ective care.
The American Medical Association survey data showed that cardiology practices havexperienced a significant reduction in practice expense over the past 5 years, when in fact
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December 8, 2009:2334–6 President’s Pageeveral surveys (4) have demonstrated a 4% to 5% annual
ncrease. It is clear that the survey data was flawed. Only
ne-third of the submitted surveys were acceptable for data
nalysis, and although we cannot review the surveys, it ap-
ears that some of the practices that responded may not
ave been representative of most private cardiology practices,
s it is hard to believe 20% of cardiology practices do not
mploy nurses (3). During the survey process, we were not
ermitted to provide explanations of the survey’s structure to
ur members, but it is apparent that other societies managed
o provide some guidance to their members. The CMS ac-
epted the survey data and did not question it, thus fostering
heir agenda of redistribution of funds to increase support for
rimary care. This is clearly the administration’s agenda. The
urvey data, however, also provide considerable increases
n reimbursement for dermatology, ophthalmology, and
nesthesia—clearly not the primary care practices in need
f revenue.
esponses
he task ahead of us is to inject reality into the practice ex-
ense information so that proper allocations of cost can be
ade. We support increased reimbursement for primary
are, but to reward primary care by eliminating private practice
f cardiology is the wrong methodology, particularly when both
he House and Senate health care reform bills contain 5% to
0% increases for primary care.
Our approach is multipronged. First, we are demonstrat-
ng the distinct value of cardiology care. This is an essential
oncept, as primary care physicians alone cannot accommo-
ate the increase in the elderly population with their high
ncidence of heart disease. Prevention of cardiovascular dis-
ase has been a major focus of cardiology practice for many
ears and will continue to be one of the prime goals of car-
iologists. While prevention is espoused by primary care for
owering costs, it will take many years to show a benefit.
any economists believe that prevention will not lower
he cost of health care (5)—patients live longer and need
ore care. The benefit is in longevity and quality of life,
ot in cost.
Second, we are aggressively working to have the CMS
elay implementation of the rule for 2010 until proper sur-
ey data can be obtained. The response to our efforts to date
as been a decision by the CMS to spread the reduction
ver 4 years so that the full impact of the cost shift will not
e felt immediately. This delays the failure of cardiology
ractices by a few years, but the end result is still the same.
he CMS also implemented a very large cut in reimburse-
ent for nuclear imaging. This was based on a revision of
uclear imaging codes, and the claim that they therefore
epresent a new procedure. Phase-ins apply only to existing
odes, as they are intended to reduce the year-to-year varia-
ion in payments for services, and new services neither have
stablished payment nor are they widespread enough to havesignificant impact on physician practices. Thus, the CMS
id not apply the 4-year phase-in to nuclear imaging under
ts new code, resulting in a major 36% hit for this service in
010. This clearly is a thinly veiled attempt to further cut
ardiology reimbursement. Does anyone in the CMS believe
hat single-photon emission computed tomography imaging
egan in 2009? It was performed on Medicare beneficiaries
ore than 3 million times in 2007 (6).
Third, we are taking our case to Congress. The CMS
akes policy based on congressional mandates. We only
chieved the 4-year phase-in through an unprecedented
rassroots advocacy effort by American College of Cardiol-
gy members to encourage more than 120 members of Con-
ress to write letters to CMS, urging them to reconsider the
roposed cuts to cardiology. The ultimate solution is to pro-
uce legislation that will force the CMS to provide trans-
arency and appropriate oversight and use truly statistically
ignificant and powered, valid, realistic, precise, and repro-
ucible data.
Finally, if all else fails, we will consider legal action to
lock the flawed data from harming the public and pre-
ent the rule from being implemented this year. While
uch an avenue is long, arduous, and expensive, with an
ncertain outcome, we owe it to our members and their
atients to try.
The plans are set. All of these activities require funding,
o this is the time to become politically active by contribut-
ng to the American College of Cardiology political action
ommittee. What is at stake is not only the survival of the
rivate practice of cardiology, but also the incredible gains
e have achieved in the battle against heart disease. What is
t stake is the delivery of office care and accessibility of
eeded studies. What is at risk is the prevention of long
ospital queues for patients for an echocardiogram or single-
hoton emission computed tomography study. An invest-
ent now will have a tremendous impact on our success.
e can demonstrate our commitment to lowering cost by
ollowing appropriate use criteria to avoid overutilization,
nd by using guideline-based care and performance measures
o improve outcomes and efficiency.
We have done our job by improving cardiovascular care
nd reducing mortality. Now is the time to defend our ac-
omplishments, our practices, and our patients.
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